AEO: Analysts' Upgrades, Downgrades
NEW YORK (TheStreet) -- CHANGE IN RATINGS
American Eagle Outfitters (AEO) downgraded at Brean Murray from Hold to Sell. $10 price target. Inventory remains high, ahead of back-to-school season.
Accretive Health (AH) initiated at JP Morgan with an Overweight rating and $27 price target. 2010 EPS estimates of 22 cents.
Accretive Health (AH) initiated at Credit Suisse with an Outperform rating and $17 price target. The company is well-positioned to benefit from the positive long-term trends in the revenue cycle industry, Credit Suisse said.
Accretive Health (AH) was initiated with a Neutral rating at Robert Baird. $15 price target. Akamai Technologies (AKAM) downgraded from Buy to Neutral at Merriman, Curhan Ford. Valuation call, as the stock is up 80% year-to-date. Ameriprise Financial (AMP) was upgraded from Hold to Buy at Citigroup. $50 price target. Estimates also boosted, as the company should be able to successfully integrate the Columbia acquisition. AthenaHealth (ATHN) initiated at JP Morgan with a Neutral rating and $34 price target. 2010 EPS estimates of 49 cents. Bristol-Myers (BMY) was initiated with a Hold rating at Soleil Securities. $28 price target. Company has a promising pipeline, but already trades at a premium valuation. Berkshire Hathaway (BRK.B) was initiated with a Buy rating at Goldman Sachs. Intrinsic value of the stock is up around $101, and the company is leveraged to a cyclical economic recovery. Covidien (COV) was downgraded from Buy to Neutral at Goldman Sachs. $48 price target. Estimates also cut, as merger-and-acquisition dilution and currency should weigh on earnings. Walt Disney (DIS) was upgraded to Buy at Goldman Sachs. $42 price target. Company has a strong film slate and parks pricing appears to be recovering. Genworth Financial (GNW) was upgraded from Equal-weight to Overweight at Morgan Stanley. $20 price target. Improving mortgage insurance results should help drive growth. KBR (KBR) was initiated with a Buy rating at Sterne Agee. $28 price target. Company could see a higher multiple, with backlog quality improving. Eli Lilly (LLY) was initiated with a Sell rating at Soleil Securities. $28 price target. Company will have several products coming off patent soon. MedAssets (MDAS) was initiated with a neutral rating and $32 price target at JP Morgan. 2010 EPS estimates of 91 cents.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
